Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID have?
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID has 97 citations in the OpenAlex counts ScholarIQ stores.
When was Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID published?
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID has 2020 year in the ScholarIQ index.
What is the open-access status of Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID?
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID has closed oa status in the ScholarIQ index.
What is the DOI of Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID?
The DOI for Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID is on the source record.
What is the PMID of Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID?
The PMID for Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID is on the source record.
What is the OpenAlex record for Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID?
The OpenAlex for Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID is on the source record.